Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Feb 3, 2009

Premium

Frank Witney has been named chief commercial officer at Affymetrix. As CCO, Witney is charged with integrating the commercial teams of Affy and its recently acquired companies, Panomics, True Materials, and USB.

Witney joined Panomics, formerly Genospectra, as CEO in 2002. Prior to that, he served as president of drug discovery tools at PerkinElmer Life sciences.

Witney was a postdoc fellow at the National Institutes of Health and holds a PhD in molecular and cell biology from Indiana University.


Allen Bombard has accepted the job of chief medical officer at Sequenom. In the role, Bombard will oversee the company's clinical and medical affairs.

Formerly, Bombard was CEO at Lenetix, chief medical officer at Sharp Mary Birch Hospital in San Diego, and he was senior vice president and director of the residency program in obstetrics and gynecology at Lutheran Medical Center in Brooklyn, NY. He also has served as a medical director for women's health at Aetna, and he was director of the Department of Obstetrics and Gynecology and Women's Health at Montefiore Medical Center and the Albert Einstein College of Medicine in Bronx, NY.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.